13 Feb Réguler l’accès aux médicaments
Comment définit-t-on la valeur des médicaments ? Sur quels critères ? Et pour quelles implications politiques ? Dans un ouvrage intitulé "Réguler l'accès aux médicaments" paru au Presses Universitaires de...
Publications
22 Jan Pourquoi les prix des traitements contre les maladies rares deviennent fous
Dans un article de L'EXPRESS, la journaliste Stéphanie Benz s'interroge sur l'explosion du marché des "médicaments orphelins", Pourquoi les prix des traitements contre les maladies rares deviennent fous, au "risque...
20 Dec Effective Market Exclusivity of New Molecular Entities for Rare and Non-rare Diseases
Kirk Kerr and Lukas Glos, economist at the Center for Drug Evaluation and Research, U.S. Food and Drug Administration, are publishing in Pharmaceutical Medicine, an article on Effective Market...
01 Oct Conscience and Courage: How Visionary CEO Henri Termeer Built a Biotech Giant and Pioneered the Rare Disease Industry
oday, Cold Spring Harbor Laboratory Press is releasing a book entitled "Conscience and Courage: How Visionary CEO Henri Termeer Built a Biotech Giant and Pioneered the Rare Disease Industry" authored...
01 Apr Economic dimensions of personalised & precision medicine
This month University of Chicago Press release a National Bureau of Economic Research Conference Report. In this book edited by ERNST R. BERNDT (MIT), DANA P. GOLDMAN (USC), AND JOHN ROWE (Columbia U), we explores altogether the intersection...
20 Nov NBER working paper #24021
Today, the National Bureau of Economics release a series of working paper presented at the last NBER Conf. on Economic Dimensions of Personalized & Precision Medicine. Among prestigious economist from Harvard, MIT, Kellogg School...
01 Jul FDA unveils plan to eliminate orphan designation backlog
The number of requests for designation of orphan drugs has increased steadily over the past five years. FDA has approximately 200 requests for designation of orphan drugs that are pending...
18 Dec OECD Science, Technology and Innovation Outlook 2016
OECD release the "OECD Science, Technology and Innovation Outlook 2016" at European Commission in Brussels to inform policy makers and analysts on recent and future changes in global science, technology and innovation. I...